Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of cocaine, lidocaine/xylometazoline and saline for intranasal analgesia
2023-506644-17-01Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- May 2024
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of cocaine, lidocaine and xylometazoline in pain (3 arms), sponsored by Rigshospitalet. Primary endpoint: Pain during procedure. Started May 2024; status: completed.
02
Drugs
cocainelidocainexylometazoline
03
Conditions
pain
Beyond the preview
Go deeper on 2023-506644-17-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506644-17-01.